Sorry if you missed this exciting event.
Save the date for our upcoming med device investment and partnering event:
featuring presentations from 30+ early-stage orthopedics and spine companies
November 10, 2009, The Grand Hyatt, San Francisco,
prior to the NASS annual meeting
Also please visit our new home page, www.biomedgps.com!
Sharon O’Reilly and Michael Mack, MD
invite you to a one-day strategic partnering and investment
conference dedicated exclusively to Vascular Start-Ups

April 22, 2009
Westin Galleria Hotel • Dallas, Texas
Held Prior to the Dallas-Leipzig International Valve Congress 2009
Finally, a “cardiac and vascular only” conference designed specifically for you. Meet and interact with a select group of leading device manufacturers and investment firms specifically interested in keeping pace with innovations - and investing in - the high-growth segments of the cardio, neuro and peripheral vascular market.
Hear presentations from 30+ emerging companies focused solely on the interventional cardiology, cardiac surgery, neurointerventional and peripheral vascular markets—all seeking funding and strategic partnerships. Take a look at our growing list of innovative Presenting Companies!
A Sampling of Attending Companies Sending their Senior Business Development Teams:
Medtronic, Cordis/J&J, Boston Scientific, Abbott Laboratories, Cook Group, Edwards Lifesciences, St. Jude Medical, CryoLife, Acorn Cardiovascular, Emergent Medical Partners, OrbusNeich Medical, Sorin Biomedica Cardio, SurModics, Longitude Capital, Emergence LLC, Sante Ventures, Versant Ventures, Orange Coast Medical Ventures, and Life Science Angels, among many others.
Hosts:
Sharon O'Reilly
Founder, former President & CEO of Medtech Insight,
Originator of the “Investment In Innovation (In3)” conference series
Michael J. Mack, MD
Medical Director of Cardiovascular Surgery & Chairman of The Heart Hospital,
Baylor Plano Research Center,
Chairman, Cardiopulmonary Research Science Technology Institute (CRSTI)
| Other Event Highlights: |
|
![]()
Where Cardiovascular Dealmakers and Emerging Companies Connect.

